Participants can expect to learn why genetic sequence-based typing (a form of “genetic fingerprinting”) may offer key evidence in proving or disproving causation in COVID-19 litigation. Armed with appropriate samples, experts can now identify the genetic sequence of the coronavirus that afflicted a patient, type that sequence, and compare it to other recorded sequences for a possible genetic match. This matching process allows for important conclusions to be drawn as to how (or where) someone may have contracted the disease. Similar typing evidence has already been used with success in other infectious disease cases and, if preparations are made now, could be the difference between winning and losing COVID-19 cases.
Adam Dinnell, Esq.
September 18, 2020